Prostate Cancer
Prostate cancer and erectile dysfunction. Which therapy when?
Published in Cancer Weekly, January 13th, 2004
"The quality of life of patients after radical prostatectomy is mainly influenced by ED and incontinence. New criteria for treatment and patient selection give us the opportunity to restore sexual function in more patients," scientists in Germany report.
"When ED is present, we should not wait for 24 months for natural restitution. ODE-5-inhibitors, intracavernosal self-injection therapy, and the vacuum constriction device are effective and conform to both patient and economic preference," wrote H. Sperling and colleagues, University of Munich, Klinikum...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-01-13)
More Articles from Cancer Weekly
- Insulin-Like Growth Factor
IIp45 antagonizes IGFBP-2 stimulation of glioma cell invasion - Anticancer Drugs
Phase I clinical trial for encapsulated anticancer drug delayed until third quarter 2004 - Gastroenterology
Survivin halts gastric cancer tumorigenicity and angiogenesis - Gastroenterology
TNF-alpha may play an early role in the malignant transformation of liver cells - Gene Suppression
Small interfering RNAs staunch genes associated with cancer growth - Geriatrics
Managing older chemo patients involves preventing pharmacologic complications - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
